These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34092194)

  • 1. Bayesian approaches to benefit-risk assessment for diagnostic tests.
    Bai T; Lan H; Tiwari R
    J Biopharm Stat; 2021 Jul; 31(4):541-558. PubMed ID: 34092194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit-risk assessment for binary diagnostic tests.
    Bai T; Huang L; Li M; Tiwari R
    J Biopharm Stat; 2019; 29(5):760-775. PubMed ID: 31498711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay.
    Vradi E; Jaki T; Vonk R; Brannath W
    Stat Methods Med Res; 2019 Aug; 28(8):2538-2556. PubMed ID: 29966502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests.
    Dendukuri N; Joseph L
    Biometrics; 2001 Mar; 57(1):158-67. PubMed ID: 11252592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
    Doi M; Takahashi F; Kawasaki Y
    Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
    Kaplan D; Chen J; Yavuz S; Lyu W
    Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian estimation of diagnostic tests accuracy for semi-latent data with covariates.
    Martinez EZ; Achcar JA; Louzada-Neto F
    J Biopharm Stat; 2005; 15(5):809-21. PubMed ID: 16078387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of diagnostic tests for low prevalence diseases: a statistical approach for leveraging real-world data to accelerate the study.
    Chen WC; Li H; Wang C; Lu N; Song C; Tiwari R; Xu Y; Yue LQ
    J Biopharm Stat; 2021 May; 31(3):375-390. PubMed ID: 33615997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian semi-parametric ROC analysis.
    Erkanli A; Sung M; Costello EJ; Angold A
    Stat Med; 2006 Nov; 25(22):3905-28. PubMed ID: 16416403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Two Bayesian Methods in Evaluation of the Absence of the Gold Standard Diagnostic Tests.
    Li T; Liu P
    Biomed Res Int; 2019; 2019():1374748. PubMed ID: 31531344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Logistic random effects regression models: a comparison of statistical packages for binary and ordinal outcomes.
    Li B; Lingsma HF; Steyerberg EW; Lesaffre E
    BMC Med Res Methodol; 2011 May; 11():77. PubMed ID: 21605357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrative Bayesian Dirichlet-multinomial regression model for the analysis of taxonomic abundances in microbiome data.
    Wadsworth WD; Argiento R; Guindani M; Galloway-Pena J; Shelburne SA; Vannucci M
    BMC Bioinformatics; 2017 Feb; 18(1):94. PubMed ID: 28178947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scale transformed power prior for use with historical data from a different outcome model.
    Alt EM; Nifong B; Chen X; Psioda MA; Ibrahim JG
    Stat Med; 2023 Jan; 42(1):1-14. PubMed ID: 36318875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
    Quan H; Zhang B; Lan Y; Luo X; Chen X
    Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian estimation of intervention effect with pre- and post-misclassified binomial data.
    Stamey JD; Seaman JW; Young DM
    J Biopharm Stat; 2007; 17(1):93-108. PubMed ID: 17219757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Method for Constructing Informative Priors for Bayesian Modeling of Occupational Hygiene Data.
    Quick H; Huynh T; Ramachandran G
    Ann Work Expo Health; 2017 Jan; 61(1):67-75. PubMed ID: 28395307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian estimation of true prevalence, sensitivity and specificity of three diagnostic tests for detection of Escherichia coli O157 in cattle feces.
    Ekong PS; Sanderson MW; Bello NM; Noll LW; Cernicchiaro N; Renter DG; Bai J; Nagaraja TG
    Prev Vet Med; 2017 Dec; 148():21-27. PubMed ID: 29157370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian latent class models with conditionally dependent diagnostic tests: a case study.
    Menten J; Boelaert M; Lesaffre E
    Stat Med; 2008 Sep; 27(22):4469-88. PubMed ID: 18551515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general framework for comparative Bayesian meta-analysis of diagnostic studies.
    Menten J; Lesaffre E
    BMC Med Res Methodol; 2015 Aug; 15():70. PubMed ID: 26315894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian Statistics for Medical Devices: Progress Since 2010.
    Campbell G; Irony T; Pennello G; Thompson L
    Ther Innov Regul Sci; 2023 May; 57(3):453-463. PubMed ID: 36869194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.